AMRX
Amneal Pharmaceuticals, Inc.Company with tickers: AMRX
CIK
1723128
CUSIP
03168L105
Shares Outstanding
319,022,792
13F Activity (30d)
264 filings
260 filers
Price
$12.79
Market Cap
$4.08B
P/E Ratio
-26.65
EPS (Diluted)
$-0.48
52W High
$15.42
52W Low
$7.02
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $695,420,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| Cost of Revenue | — | ||||
| Gross Profit | $255,891,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| Operating Expenses | — | ||||
| Research & Development | $40,040,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $100,347,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| Net Income | $12,195,000 | USD | 2025-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $0.04 | USD/shares | 2025-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $0.04 | USD/shares | 2025-03-31 | 10-Q | 2026-05-07 |